TTTimur M. Topuzov

Timur M. Topuzov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Timur M. Topuzov has a total of 150 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Robot-assisted radical prostatectomy: Impact of robotic program implementation on clinical and organizational outcomes in a specialized urological hospital

    by S. V. Popov, R. G. Guseynov, T. M. Topuzov, P. V. Vyazovtsev, K. E. Chernov, T. A. Lelyavina, I. Yu. Kopytova, A. Kh. Beshtoev, E. A. Malyshev, R. O. Grushevsky, et al.

    Background. Robot-assisted radical prostatectomy is increasingly used for the surgical treatment of localized prostate cancer; however, its clinical impact should be assessed using perioperative, oncological, functional, and organizational outcomes. Aim. To evaluate the impact of implementing a robot-assisted radical prostatectomy program on clinical and organizational outcomes in a specialized urological hospital. Materials and methods. This retrospective single-center study included 823 patients who underwent radical prostatectomy between 2021 and 2024. The main comparative analysis comprised 269 robot-assisted and 181 laparoscopic procedures. Perioperative, oncological, and functional outcomes were assessed. Multivariate analysis was performed for the principal endpoints. Results. Blood loss ≥200 mL occurred less frequently in robot-assisted than laparoscopic prostatectomy (17.8 % versus 33.1 %; p p = 0.001). Median postoperative hospital stay was 12 [9; 14] versus 13 [11; 17] days ( p 240 min (aOR = 0.52; 95 % CI 0.28–0.96) and duration of hospital stay (–0.85 days; p = 0.030). Positive surgical margins occurred in 11.9 % and 16.6 % of patients, respectively ( p = 0.158), with no independent association with surgical approach. Conclusion. The main benefits of the robotic program were observed in perioperative and organizational outcomes, while oncological radicality remained comparable. Implementation of robot-assisted radical prostatectomy was associated with reduced blood loss, fewer prolonged procedures, and shorter hospitalization without deterioration in oncological outcomes.

  • Open Access

    Comparison of MRI Semiology of PI-RADS 3 and PI-RADS 4 Categories with the Results of Stereotactic MRI-Guided Prostate Biopsy

    by Дарья Игоревна Куплевацкая, Владимир Игоревич Куплевацкий, Марлен Эскендерович Топузов, Сергей Сергеевич Водопьян, Никита Валерьевич Сурнин, Татьяна Николаевна Трофимова, Тимур Марленович Топузов, Михаил Михайлович Атамась, Сабина Фамилевна Абузарова

    Введение. Рак предстательной железы (РПЖ) – одно из наиболее распространённых онкологических заболеваний у мужчин. Мультипараметрическая МРТ (мпМРТ) позволяет стратифицировать очаги по вероятности клинически значимого РПЖ согласно системе PI‑RADS, однако тактика при PI‑RADS 3 остаётся дискуссионной. Цель. Сопоставить данные МР‑семиотики категорий PI‑RADS 3 и PI‑RADS 4 с результатами стереотаксической (СТ) МР‑направленной биопсии ПЖ. Материалы и методы. Проведён ретроспективный анализ 80 МР‑исследований ПЖ, выполненных в 2019-2024 гг. Оценено 98 таргетных очагов PI‑RADS 3 (n=27) и PI‑RADS 4 (n=71). Всем пациентам выполнена МР‑направленная СТ биопсия под контролем МРТ с последующим гистологическим исследованием. Результаты. Верифицирован РПЖ в 78 из 98 очагов - 79,6% (70,8%; 86,6%). Частота выявления РПЖ составила 48,1% (30,3%; 66,4%) для PI‑RADS 3 и 91,5% (83,4%; 96,4%) для PI‑RADS 4 (p<0,0001). Для PI‑RADS 3 преобладали очаги с Глисон 6 (3+3), тогда как для PI‑RADS 4 – Глисон 7 (3+4). В 44,8% (34,2%; 55,9%) случаев дополнительно выявлен мультифокальный рост вне таргетного очага, при этом степень дифференцировки опухоли в дополнительных очагах рака была аналогичной или выше, чем в установленном таргетном очаге. Медианное значение для размера очага (см3) составило 0,295 (0,13; 0,59), медианное значение для суммы Глисон 7 (6; 7), значимой корреляции между ними не обнаружено (p=0,08). Выводы. Категория PI‑RADS 4 ассоциирована с высокой вероятностью кзРПЖ и требует обязательной таргетной биопсии. При PI‑RADS 3 выполнение биопсии должно определяться индивидуально, с учётом ПСА, возраста и анамнеза. Полученные данные подтверждают ограниченность системы PI‑RADSv2.1 в дифференциации доброкачественных и злокачественных изменений.

  • Comparison of histological results of transperineal and transrectal fusion biopsies of the prostate gland with the results of pathomorphological examination after radical prostatectomy: a retrospective cohort study

    by Sergey V. Popov, Andrey V. Bashin, Aleksey V. Tsoy, Timur M. Topuzov, Pavel V. Vyazovtsev, Sergey M. Malevich, Maksim L. Gorelik, Irina Yu. Kopytova, Sergey S. Vodopyan

    BACKGROUND: Prostate fusion biopsy is the primary method for diagnosing prostate cancer (PCa). Currently, the transrectal (TR) and transperineal (TP) approaches are used in clinical practice for prostate fusion biopsy. It remains unclear whether the approach affects the accuracy of preoperative tumor aggressiveness grading, which may subsequently influence treatment strategy. AIM: To conduct a comparative assessment of the diagnostic accuracy of transperineal versus transrectal prostate fusion biopsy based on correlation with postoperative histopathological findings. METHODS: This retrospective cohort study included 210 patients (August 2024 – March 2026) with PI-RADS ≥ 3 lesions on multiparametric magnetic resonance imaging (mpMRI, version 2.1) who underwent fusion biopsy followed by robot-assisted radical prostatectomy (RARP). The TR biopsy group comprised 138 patients, and the TP biopsy group comprised 72 patients. Concordance between biopsy and surgical specimen histology was analyzed: agreement, upgrading and downgrading of ISUP grade (International Society of Urological Pathology, 2019). Cohen’s weighted kappa coefficient was calculated, and multivariable logistic regression analysis was performed. RESULTS: The groups were comparable in total PSA level (p = 0.172) and PSA density (p = 0.163) but differed in age (p = 0.012) and number of biopsy cores taken (p = 0.0002). Cohen’s kappa coefficient was 0.64 (95% CI: 0.55–0.73) for TR and 0.67 (95% CI: 0.56–0.78) for TP fusion biopsy (p = 0.76). Exact ISUP grade agreement was observed in 73.2% (TR) and 77.8% (TP). Upgrading occurred in 15.9% of the TR group and 15.3% of the TP group (p = 0.91). Downgrading occurred in 10.9% of the TR group and 6.9% of the TP group (p = 0.21). In patients with initial ISUP 1, upgrading after RARP occurred in 28.6% of the TR group and 22.2% of the TP group (p = 0.51). Multivariable analysis revealed no statistically significant factors (total PSA level, PSA density, age, number of biopsy cores, access type) associated with ISUP grade discordance (p 0.05). A trend towards increased discordance probability with higher PSA density was noted (p = 0.097, OR = 1.280 per 0.1 unit). Adverse events such as infectious and hemorrhagic complications and pain were not studied in this work. CONCLUSION: Transperineal and transrectal prostate fusion biopsies demonstrate high and comparable diagnostic accuracy. No independent risk factors for discordance were identified. PSA density may be considered a potential factor warranting further study.

  • Open Access

    Surgical correction of cystocele using a flap from the anterior vaginal wall: original article

    by Sergey V. Popov, Anton S. Kondratev, Timur M. Topuzov, Anastasia O. Zaytseva, Ivan A. Labetov, Amaliia A. Musorina, Vladislava S. Korneva

    Background. Among the forms of pelvic organ prolapse, cystocele occupies a leading position in terms of prevalence. The most common method of cystocele repair is anterior colporrhaphy; however, the recurrence rate after this type of surgical correction remains relatively high. Aim. To evaluate the efficacy and safety of the developed method for cystocele correction using a vascularized pedicled flap created from the excess tissue of the anterior vaginal wall. Materials and methods. The study included 23 patients with grade III–IV cystocele who underwent surgery using the proposed technique. Postoperative follow-up was performed at 2, 6, and 12 months and included vaginal examination, prolapse assessment according to the POP-Q system, and completion of questionnaires (PFDI-20, ICIQ-SF). Results. All patients presented with grade III–IV anterior vaginal wall prolapse, grade II–IV apical prolapse, and grade II–IV posterior vaginal wall prolapse. In addition to the studied cystocele correction technique, all patients underwent sacrospinous uterine fixation using a synthetic mesh implant, posterior colporrhaphy, and perineoplasty. The mean operative time was 113±25 minutes. There was 1 (4.3%) case of intraoperative bladder injury, which did not affect surgical outcomes but required bladder drainage for 7 days. The mean intraoperative blood loss was 67±14 ml. Two (8.7%) cases of hyperthermia were recorded in the early postoperative period and were resolved with antibacterial therapy and nonsteroidal antipyretic drugs. During follow-up, 2 (8.7%) cystocele recurrences were detected; however, repeat surgical correction was not performed. The remaining patients demonstrated satisfactory outcomes. The most common early postoperative adverse event was urinary retention (13%). All patients reported improvement in quality of life based on questionnaire results. Cystocele correction was successful in 21 (91.3%) patients, and overall treatment satisfaction was 87%. Conclusion. Cystocele correction using a vaginal flap is a safe and effective method for the treatment of anterior vaginal wall prolapse.

  • AI-assisted cognitive targeted biopsy: a new approach to prostate cancer diagnosis

    by Marlen E. Topuzov, Sergey S. Vodopyan, Daria I. Kuplevatskaya, Timur M. Topuzov, Mikhail M. Atamas, Sabina F. Abuzarova

    BACKGROUND: Prostate cancer ranks second in prevalence among male malignancies and is diagnosed via biopsy. However, the standard 12-core systematic biopsy often demonstrates low accuracy. Advancing targeted navigation techniques is a key factor in improving the detection of clinically significant forms of the disease. AIM: To develop a new strategy for cognitive targeted biopsy using artificial intelligence (AI-COG-TB) and to conduct a comparative analysis of the diagnostic performance of various prostate cancer detection methods. METHODS: This prospective multicenter study included 233 patients with prostate-specific antigen 2.5 ng/mL and Prostate Imaging-Reporting and Data System ≥ 3. Five approaches were compared: transrectal ultrasound-guided systematic biopsy (TRUS-TB, n = 50), cognitive biopsy (COG-TB, n = 40), MRI-transrectal ultrasound fusion-guided biopsy (FUS-TB, n = 49), in-bore magnetic resonance imaging-guided biopsy (IB-TB, n = 49), and cognitive biopsy with artificial intelligence-assisted segmentation (AI-COG-TB, n = 45). Results were evaluated based on the cancer detection rate and risk stratification according to the International Society of Urological Pathology (ISUP) groups. RESULTS: The overall prostate cancer detection rate was 98% for in-bore magnetic resonance imaging-guided biopsy (IB-TB), 91.8% for fusion-guided biopsy (FUS-TB), and 88.9% for cognitive biopsy with artificial intelligence-assisted segmentation (AI-COG-TB), which significantly exceeded the rates for systematic biopsy (TRUS-TB: 78%) and cognitive biopsy (COG-TB: 75%). The in-bore magnetic resonance imaging-guided biopsy (IB-TB) demonstrated the highest efficacy in detecting clinically significant prostate cancer: 75.5% of cases, with the lowest proportion of indolent forms (24.5%). In a multivariate binary logistic regression model, the strongest predictors of cancer detection compared to the standard were in-bore magnetic resonance imaging-guided biopsy (IB-TB) (odds ratio [OR] 26.01; p = 0.003), fusion-guided biopsy (FUS-TB) (OR 5.16; p = 0.015), and cognitive biopsy with artificial intelligence-assisted segmentation (AI-COG-TB) (OR 3.56; p = 0.046). Cognitive biopsy without AI support (COG-TB) showed no statistically significant advantages over the systematic method (p = 0.771). CONCLUSION: The AI-COG-TB technique serves as an effective and economically accessible alternative to fusion biopsy (FUS-TB), significantly improving diagnostic accuracy compared to cognitive biopsy (COG-TB). However, in-bore magnetic resonance imaging-guided biopsy (IB-TB) remains the method of choice for identifying aggressive cancer forms and minimizing the overdiagnosis of indolent tumors.

  • CONSERVATIVE TREATMENT OF PELVIC ORGAN PROLAPSE: CURRENT APPROACHES (REVIEW)

    by Sergey V. Popov, Anton S. Kondratiev, Timur M. Topuzov, Amalia A. Musorina

    Objective. This study aims to evaluate and summarize the existing data regarding the effectiveness and role of conservative treatment approaches for pelvic organ prolapse (POP), with the goal of establishing their evidence base and position within clinical practice. Materials and Methods. A comprehensive systematic search of relevant publications was performed across the PubMed, Scopus, Cochrane Library, eLibrary.ru, and Google Scholar databases, utilizing keywords associated with the conservative management of POP. From a total of 87 identified sources, 59 studies that met the established quality and relevance criteria were selected for the final analysis. Conclusion. Among the conservative management strategies for POP, pelvic floor muscle training demonstrates the strongest evidence base, with its effectiveness further augmented by the use of biofeedback techniques. Pessaries are recognized as a highly effective intervention for alleviating symptoms and enhancing quality of life, particularly when fitted to the individual. Conversely, physical modalities such as laser and radiofrequency therapy, along with PRP therapy, present limited and often conflicting evidence. Additionally, local estrogen therapy serves as an adjunctive treatment and does not influence the stage of prolapse. It is essential that conservative treatment be tailored to the individual, taking into account the stage of prolapse, presenting symptoms, and specific patient needs.

  • THE ROLE OF PARAVAGINAL DEFECTS OF THE PUBOCERVICAL FASCIA IN THE FORMATION OF CYSTOCELE

    by Sergey V. Popov, Anton S. Kondratiev, Timur M. Topuzov, Anzhelika Yu. Maslova, Ivan V. Kulikov

    Objective. To analyze the role of paravaginal defects of the pubocervical fascia (PCF) in the development of anterior–apical pelvic organ prolapse in women and to assess their contribution to the pathogenesis of cystocele in light of current concepts of pelvic anatomy and support mechanisms. Materials and Methods. An analytical review of the literature published between 1909 and 2023 was performed using PubMed, Scopus, Google Scholar, and eLibrary databases. The analysis included studies addressing pelvic floor anatomy, mechanisms of pelvic organ prolapse development, modern imaging techniques including magnetic resonance imaging and three-dimensional pelvic organ modeling, as well as outcomes of surgical correction of pubocervical fascia defects. Particular attention was paid to studies evaluating the impact of impaired lateral vaginal attachment on the development of anterior and apical prolapse components. Results. The pathogenesis of anterior vaginal wall prolapse is multifactorial and involves connective tissue damage, impaired apical support, and enlargement of the genital hiatus. One of the key factors contributing to cystocele formation is disruption of the attachment of the pubocervical fascia to the tendinous arch of the pelvic fascia, resulting in paravaginal defects. Contemporary data obtained using MRI visualization and 3D reconstruction of pelvic structures confirm the significant role of lateral vaginal support defects, particularly in the distal third of the vagina. Standard anterior colporrhaphy performed in the presence of paravaginal defects is frequently associated with recurrence, whereas surgical restoration of lateral vaginal support demonstrates effectiveness ranging from 65% to 95% and provides more stable anatomical outcomes. Conclusion. Paravaginal defects represent an important, but not the only, component in the pathogenesis of anterior vaginal wall prolapse. Current evidence supports the need for comprehensive assessment of pelvic support levels and the development of a personalized surgical approach to the treatment of anterior-apical prolapse.

  • Open Access

    PLATELET‑ENRICHED AUTOPLASMA FOR ERECTILE DYSFUNCTION AFTER ROBOT‑ASSISTED RADICAL PROSTATECTOMY

    by Sergey V. Popov, Timur M. Topuzov, Maxim L. Gorelik, Pavel V. Vyazovtsev, Kirill E. Chernov, Maria Yu. Egorova

    Introduction. Currently, the main surgical treatment option for prostate cancer is radical prostatectomy, which often results in damage to the neurovascular bundles, which subsequently causes erectile dysfunction. At the same time, the properties of platelet-rich autoplasm are known, which contributes to the restoration of these structures and can be used to restore erectile function after this surgical treatment. Objective. To evaluate the effectiveness and safety of the platelet-enriched autoplasma injection technique after robot-assisted radical prostatectomy. Materials and Methods. A prospective analysis of the treatment results of 120 patients with localized low-risk prostate cancer was conducted, which were divided into 4 groups. Group 1 (n=30) included patients who underwent surgery without platelet-enriched autoplasm and type 5 iFDE, Group 2 (n=30) with type 5 iFDE taking, Group 3 (n=30) with intraoperative administration of platelet-enriched autoplasm, and Group 4 (n=30) – with combined intraoperative administration of autoplasm and type 5 iFDE taking. The research methods used included the International Index of Erectile Function (ICEF-5) questionnaire, the Erectile Hardness Scale (EHS), and the Hospital Depression and Anxiety Scale (HADS). Results. The study showed that Groups 2 and 3 did not differ from each other, since the Mann-Whitney criterion was not significant (p>0.05) both before and after surgery. At the same time, Groups 2 and 3 showed better results than Group 1. In both cases, there were no differences between the survey results before surgery, but after 3, 6 and 12 months the results were different, in Groups 2 and 3 they were better than in group 1. At the 95% significance level, group 4 performed the best. The results of comparing this group with Groups 1, 2 and 3 using the Mann-Whitney test turned out to be significant after surgery at 3.6 and 12 months. Erectile dysfunction decreased after surgery, while Group 4 showed the best results. Anxiety levels before surgery were higher in all Groups than after. At the same time, the lowest level of anxiety was observed in Group 4. The study also reflected the lack of data on the biochemical recurrence of prostate cancer in all groups during dynamic follow-up throughout the year. The study also reflected the lack of data on the biochemical recurrence of prostate cancer in all groups during dynamic follow-up throughout the year. Conclusions. The data obtained indicate the effectiveness and safety of the platelet-rich autoplasm injection method in robot-assisted radical prostatectomy, and also allow it to be considered an effective method of penile rehabilitation.

  • Open Access

    Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate Carcinomas

    by Aglaya G. Iyevleva, Svetlana N. Aleksakhina, Anna P. Sokolenko, Ekaterina A. Otradnova, Alisa S. Nikitina, Kira A. Kashko, Maria V. Syomina, Anna D. Shestakova, Ekaterina S. Kuligina, Natalia S. Morozova, et al.

    Homologous recombination deficiency (HRD) resulting from inactivation of BRCA1/2 genes promotes chromosomal instability and renders tumor cells susceptible to platinum derivatives and PARP inhibitors (PARPi). The contribution of alterations in other homologous recombination repair (HRR) genes to HRD remains understudied. This investigation aimed to analyze the spectrum of mutations in 34 HRR genes in prostate carcinomas (PCs) and study the relationship between HRR status and HRD. HRR mutations and HRD scores were examined by NGS in 1131 and 680 PCs, respectively. Pathogenic or likely pathogenic variants in HRR genes were detected in 216/1131 cases (19.1%). HRD, defined by an HRD score cut-off of ≥42, was observed more frequently in HRR-mutated than in wild-type tumors (23/120 (19.2%) vs. 29/560 (5.2%), p < 0.0001). The highest HRD scores were detected in PCs with biallelic inactivation of the BRCA2 or PALB2 genes, as well as in tumors with BRIP1 mutations. HRD was also occasionally seen in PCs with ATM, NBN, FANCM, BRCA1 and CDK12 alterations, but never in cases with CHEK2 mutations. HRD was significantly more associated with aggressive PC features than HRR mutations. The majority of CDK12-mutated tumors exhibited a distinct type of copy number variations (CNV)–a tandem duplication phenotype. Our study suggests that the selection of PC patients for PARPi treatment requires a significant revision of existing attitudes towards tumor genetic profiling.


  • Open Access

    Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate Carcinomas

    by Aglaya G. Iyevleva, Svetlana N. Aleksakhina, Anna P. Sokolenko, Ekaterina A. Otradnova, Alisa S. Nikitina, Kira A. Kashko, Maria V. Syomina, Anna D. Shestakova, Ekaterina Sh. Kuligina, Natalia S. Morozova, et al.

    Homologous recombination deficiency (HRD) resulting from inactivation of BRCA1/2 genes promotes chromosomal instability and renders tumor cells susceptible to platinum derivatives and PARP inhibitors (PARPi). The contribution of alterations in other homologous recombination repair (HRR) genes to HRD remains understudied. This investigation aimed to analyze the spectrum of mutations in 34 HRR genes in prostate carcinomas (PCs), and to study relationships between HRR status and HRD. HRR mutations and HRD scores were examined by NGS in 1131 and 680 PCs, respectively. Pathogenic or likely pathogenic variants in HRR genes were detected in 216/1131 cases (19.1%). HRD, defined by the cut-off ≥ 42, was observed more frequently in HRR-mutated vs. wild-type tumors (23/120 (19.2%) vs. 29/560 (5.2%), p < 0.0001). The highest HRD scores were detected in PCs with biallelic inactivation of BRCA2 or PALB2 genes, as well in tumors with BRIP1 mutations. HRD was also occasionally seen in PCs with ATM, NBN, FANCM, BRCA1 and CDK12 alterations, but never in cases with CHEK2 mutations. HRD was more significantly associated with aggressive PC features than HRR mutations. The majority of CDK12-mutated tumors demonstrated a distinct type of copy number variations (CNV), i.e., so-called tandem duplication phenotype. Our study suggests that the selection of PC patients for PARPi treatment requires significant revision of existing attitudes towards tumor genetic profiling.